Masimo (MASI) Stock Forecast, Price Target & Predictions
MASI Stock Forecast
Masimo stock forecast is as follows: an average price target of $160.20 (represents a 8.69% upside from MASI’s last price of $147.39) and a rating consensus of 'Buy', based on 11 wall street analysts offering a 1-year stock forecast.
MASI Price Target
MASI Analyst Ratings
Masimo Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Oct 14, 2024 | Marie Thibault | BTIG | $170.00 | $140.62 | 20.89% | 15.34% |
Sep 20, 2024 | Jason Bednar | Piper Sandler | $165.00 | $114.61 | 43.97% | 11.95% |
Jun 03, 2024 | Jason Bednar | Piper Sandler | $160.00 | $124.50 | 28.51% | 8.56% |
Apr 15, 2024 | Rick Wise | Stifel Nicolaus | $170.00 | $137.92 | 23.26% | 15.34% |
Mar 25, 2024 | Rick Wise | Stifel Nicolaus | $148.00 | $139.43 | 6.15% | 0.41% |
Mar 25, 2024 | Sean Lavin | BTIG | $166.00 | $139.43 | 19.06% | 12.63% |
Mar 25, 2024 | Vik Chopra | Wells Fargo | $160.00 | $139.83 | 14.42% | 8.56% |
Jul 18, 2023 | Mike Matson | Needham | $136.00 | $118.98 | 14.30% | -7.73% |
May 10, 2023 | Mike Matson | Needham | $207.00 | $174.55 | 18.59% | 40.44% |
Dec 15, 2022 | Marie Thibault | BTIG | $180.00 | $145.00 | 24.14% | 22.12% |
Masimo Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | 1 | 2 | 7 |
Avg Price Target | $170.00 | $167.50 | $162.71 |
Last Closing Price | $147.39 | $147.39 | $147.39 |
Upside/Downside | 15.34% | 13.64% | 10.39% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Oct 18, 2024 | Piper Sandler | Overweight | Overweight | Hold |
Sep 25, 2024 | BTIG | Buy | Buy | Hold |
Sep 20, 2024 | Needham | Hold | Hold | Hold |
Sep 20, 2024 | Piper Sandler | Overweight | Overweight | Hold |
Aug 07, 2024 | Piper Sandler | Overweight | Overweight | Hold |
Jun 25, 2024 | Piper Sandler | Overweight | Overweight | Hold |
Jun 03, 2024 | Piper Sandler | Neutral | Overweight | Upgrade |
Mar 25, 2024 | Wells Fargo | Equal-Weight | Overweight | Upgrade |
Nov 08, 2023 | Wells Fargo | Equal-Weight | Equal-Weight | Hold |
Oct 27, 2023 | Needham | Buy | Buy | Hold |
Masimo Financial Forecast
Masimo Revenue Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $548.90M | $478.90M | $455.30M | $565.00M | $617.00M | $549.30M | $565.30M | $304.24M | $295.05M | $307.41M | $305.12M | $299.04M | - | $278.11M | $300.95M | $269.63M | $247.51M | $229.01M |
Avg Forecast | $678.43M | $570.24M | $563.75M | $561.26M | $643.37M | $537.57M | $530.05M | $524.92M | $607.59M | $502.87M | $493.92M | $487.70M | $545.69M | $493.90M | $478.27M | $557.87M | $602.49M | $534.88M | $540.57M | $308.04M | $320.52M | $295.80M | $295.64M | $295.28M | $287.52M | $256.58M | $290.09M | $259.90M | $243.79M | $221.92M |
High Forecast | $678.43M | $570.24M | $563.75M | $561.26M | $643.37M | $537.57M | $530.05M | $524.92M | $607.59M | $506.30M | $493.92M | $487.72M | $547.84M | $496.37M | $478.27M | $557.87M | $602.49M | $534.88M | $540.57M | $308.04M | $320.52M | $295.80M | $295.64M | $295.28M | $287.52M | $256.58M | $290.09M | $259.90M | $243.79M | $221.92M |
Low Forecast | $678.43M | $570.24M | $563.75M | $561.26M | $643.37M | $537.57M | $530.05M | $524.92M | $607.59M | $498.29M | $493.92M | $487.68M | $542.57M | $491.42M | $478.27M | $557.87M | $602.49M | $534.88M | $540.57M | $308.04M | $320.52M | $295.80M | $295.64M | $295.28M | $287.52M | $256.58M | $290.09M | $259.90M | $243.79M | $221.92M |
# Analysts | 3 | 3 | 3 | 4 | 3 | 4 | 5 | 2 | 3 | 7 | 3 | 3 | 6 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 8 | 8 | 8 | 8 | 12 | 12 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.01% | 0.97% | 0.95% | 1.01% | 1.02% | 1.03% | 1.05% | 0.99% | 0.92% | 1.04% | 1.03% | 1.01% | - | 1.08% | 1.04% | 1.04% | 1.02% | 1.03% |
Masimo EBITDA Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 3 | 3 | 3 | 4 | 3 | 4 | 5 | 2 | 3 | 7 | 3 | 3 | 6 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 8 | 8 | 8 | 8 | 12 | 12 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $87.40M | $25.20M | $29.30M | $64.10M | $153.60M | $54.80M | $22.10M | $69.17M | $73.50M | $76.99M | $74.17M | $74.37M | - | $68.11M | $70.93M | $77.73M | $70.68M | $61.22M |
Avg Forecast | $143.68M | $120.77M | $119.40M | $118.87M | $136.26M | $113.85M | $112.26M | $111.17M | $128.68M | $106.50M | $104.61M | $77.03M | $115.57M | $104.60M | $101.29M | $70.02M | $85.11M | $113.28M | $114.49M | $63.66M | $77.37M | $62.65M | $62.61M | $62.54M | $60.89M | $54.34M | $61.44M | $73.62M | $51.63M | $47.00M |
High Forecast | $143.68M | $120.77M | $119.40M | $118.87M | $136.26M | $113.85M | $112.26M | $111.17M | $128.68M | $107.23M | $104.61M | $92.43M | $116.03M | $105.13M | $101.29M | $84.03M | $102.13M | $113.28M | $114.49M | $76.39M | $92.85M | $62.65M | $62.61M | $62.54M | $60.89M | $54.34M | $61.44M | $88.35M | $51.63M | $47.00M |
Low Forecast | $143.68M | $120.77M | $119.40M | $118.87M | $136.26M | $113.85M | $112.26M | $111.17M | $128.68M | $105.53M | $104.61M | $61.62M | $114.91M | $104.08M | $101.29M | $56.02M | $68.09M | $113.28M | $114.49M | $50.93M | $61.90M | $62.65M | $62.61M | $62.54M | $60.89M | $54.34M | $61.44M | $58.90M | $51.63M | $47.00M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.76% | 0.24% | 0.29% | 0.92% | 1.80% | 0.48% | 0.19% | 1.09% | 0.95% | 1.23% | 1.18% | 1.19% | - | 1.25% | 1.15% | 1.06% | 1.37% | 1.30% |
Masimo Net Income Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 3 | 3 | 3 | 4 | 3 | 4 | 5 | 2 | 3 | 7 | 3 | 3 | 6 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 8 | 8 | 8 | 8 | 12 | 12 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $34.00M | $10.60M | $15.70M | $21.30M | $40.90M | $37.90M | $18.10M | $46.59M | $70.67M | $57.77M | $50.23M | $53.38M | - | $49.41M | $55.77M | $64.46M | $52.92M | $49.09M |
Avg Forecast | $79.54M | $65.99M | $64.31M | $62.47M | $75.91M | $54.03M | $53.99M | $53.60M | $76.69M | $45.42M | $41.54M | $52.49M | $49.01M | $32.88M | $34.80M | $47.72M | $67.58M | $50.20M | $65.25M | $43.38M | $61.43M | $49.52M | $49.06M | $47.51M | $46.67M | $33.57M | $44.03M | $60.21M | $47.29M | $39.48M |
High Forecast | $79.54M | $65.99M | $64.31M | $62.47M | $75.91M | $54.03M | $53.99M | $53.60M | $76.69M | $45.96M | $41.54M | $62.99M | $51.16M | $33.38M | $34.80M | $57.26M | $81.09M | $50.20M | $66.53M | $52.06M | $73.72M | $49.52M | $49.06M | $47.51M | $46.67M | $33.57M | $44.03M | $72.25M | $47.29M | $39.48M |
Low Forecast | $79.54M | $65.99M | $64.31M | $62.47M | $75.91M | $54.03M | $53.99M | $53.60M | $76.69M | $44.88M | $41.54M | $41.99M | $43.62M | $32.38M | $34.80M | $38.18M | $54.06M | $50.20M | $63.97M | $34.71M | $49.15M | $49.52M | $49.06M | $47.51M | $46.67M | $33.57M | $44.03M | $48.16M | $47.29M | $39.48M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.69% | 0.32% | 0.45% | 0.45% | 0.61% | 0.76% | 0.28% | 1.07% | 1.15% | 1.17% | 1.02% | 1.12% | - | 1.47% | 1.27% | 1.07% | 1.12% | 1.24% |
Masimo SG&A Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 3 | 3 | 3 | 4 | 3 | 4 | 5 | 2 | 3 | 7 | 3 | 3 | 6 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 8 | 8 | 8 | 8 | 12 | 12 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $159.80M | $156.10M | $151.70M | $196.30M | $185.80M | $174.60M | $188.30M | $108.90M | $90.34M | $100.65M | $93.83M | $96.70M | - | $90.38M | $98.46M | $89.88M | $81.94M | $80.35M |
Avg Forecast | $220.40M | $185.25M | $183.14M | $182.33M | $209.01M | $174.64M | $172.19M | $170.53M | $197.38M | $163.36M | $160.46M | $122.68M | $177.28M | $160.45M | $155.37M | $111.53M | $103.07M | $173.76M | $175.61M | $101.39M | $93.70M | $96.09M | $96.04M | $95.93M | $93.40M | $83.35M | $94.24M | $83.95M | $79.20M | $72.10M |
High Forecast | $220.40M | $185.25M | $183.14M | $182.33M | $209.01M | $174.64M | $172.19M | $170.53M | $197.38M | $164.48M | $160.46M | $147.22M | $177.97M | $161.25M | $155.37M | $133.83M | $123.68M | $173.76M | $175.61M | $121.67M | $112.44M | $96.09M | $96.04M | $95.93M | $93.40M | $83.35M | $94.24M | $100.74M | $79.20M | $72.10M |
Low Forecast | $220.40M | $185.25M | $183.14M | $182.33M | $209.01M | $174.64M | $172.19M | $170.53M | $197.38M | $161.88M | $160.46M | $98.15M | $176.26M | $159.64M | $155.37M | $89.22M | $82.46M | $173.76M | $175.61M | $81.11M | $74.96M | $96.09M | $96.04M | $95.93M | $93.40M | $83.35M | $94.24M | $67.16M | $79.20M | $72.10M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.90% | 0.97% | 0.98% | 1.76% | 1.80% | 1.00% | 1.07% | 1.07% | 0.96% | 1.05% | 0.98% | 1.01% | - | 1.08% | 1.04% | 1.07% | 1.03% | 1.11% |
Masimo EPS Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 3 | 3 | 3 | 4 | 3 | 4 | 5 | 2 | 3 | 7 | 3 | 3 | 6 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 8 | 8 | 8 | 8 | 12 | 12 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | $0.63 | $0.20 | $0.30 | $0.40 | $0.76 | $0.72 | $0.34 | $0.84 | $1.28 | $1.05 | $0.91 | $0.97 | - | $0.90 | $1.02 | $1.20 | $0.99 | $0.92 |
Avg Forecast | $1.46 | $1.22 | $1.18 | $1.15 | $1.40 | $1.00 | $0.99 | $0.99 | $1.41 | $0.84 | $0.77 | $0.70 | $0.90 | $0.61 | $0.64 | $0.83 | $1.18 | $0.92 | $1.20 | $0.90 | $1.10 | $0.91 | $0.90 | $0.88 | $0.86 | $0.62 | $0.81 | $0.91 | $0.87 | $0.73 |
High Forecast | $1.46 | $1.22 | $1.18 | $1.15 | $1.40 | $1.00 | $0.99 | $0.99 | $1.41 | $0.85 | $0.77 | $0.70 | $0.94 | $0.61 | $0.64 | $0.83 | $1.18 | $0.92 | $1.23 | $0.90 | $1.10 | $0.91 | $0.90 | $0.88 | $0.86 | $0.62 | $0.81 | $0.91 | $0.87 | $0.73 |
Low Forecast | $1.46 | $1.22 | $1.18 | $1.15 | $1.40 | $1.00 | $0.99 | $0.99 | $1.41 | $0.83 | $0.77 | $0.70 | $0.80 | $0.60 | $0.64 | $0.83 | $1.18 | $0.92 | $1.18 | $0.90 | $1.10 | $0.91 | $0.90 | $0.88 | $0.86 | $0.62 | $0.81 | $0.91 | $0.87 | $0.73 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.70% | 0.33% | 0.47% | 0.48% | 0.65% | 0.78% | 0.28% | 0.93% | 1.16% | 1.15% | 1.01% | 1.11% | - | 1.46% | 1.26% | 1.32% | 1.14% | 1.27% |
Masimo Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
TNDM | Tandem Diabetes Care | $32.85 | $81.22 | 147.25% | Buy |
TMDX | TransMedics Group | $84.97 | $126.75 | 49.17% | Buy |
LIVN | LivaNova | $49.01 | $70.50 | 43.85% | Buy |
CNMD | CONMED | $70.47 | $96.00 | 36.23% | Buy |
NARI | Inari Medical | $48.93 | $66.11 | 35.11% | Buy |
INSP | Inspire Medical Systems | $192.71 | $238.00 | 23.50% | Buy |
DXCM | DexCom | $69.70 | $81.36 | 16.73% | Buy |
PODD | Insulet | $237.44 | $270.93 | 14.10% | Buy |
MASI | Masimo | $147.39 | $160.20 | 8.69% | Buy |
PEN | Penumbra | $229.51 | $224.85 | -2.03% | Buy |
GKOS | Glaukos | $131.38 | $119.33 | -9.17% | Buy |
SWAV | ShockWave Medical | $334.75 | $258.17 | -22.88% | Hold |
MASI Forecast FAQ
Is Masimo a good buy?
Yes, according to 11 Wall Street analysts, Masimo (MASI) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 7 'Buy' recommendations, accounting for 63.64% of MASI's total ratings.
What is MASI's price target?
Masimo (MASI) average price target is $160.2 with a range of $136 to $170, implying a 8.69% from its last price of $147.39. The data is based on 11 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Masimo stock go up soon?
According to Wall Street analysts' prediction for MASI stock, the company can go up by 8.69% (from the last price of $147.39 to the average price target of $160.2), up by 15.34% based on the highest stock price target, and down by -7.73% based on the lowest stock price target.
Can Masimo stock reach $200?
MASI's average twelve months analyst stock price target of $160.2 does not support the claim that Masimo can reach $200 in the near future.
What is Masimo's current price target trend?
1 Wall Street analyst forecast a $170 price target for Masimo (MASI) this month, up 15.34% from its last price of $147.39. Compared to the last 3 and 12 months, the average price target increased by 13.64% and increased by 10.39%, respectively.
What are Masimo's analysts' financial forecasts?
Masimo's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $2.24B (high $2.24B, low $2.24B), average EBITDA is $473.54M (high $473.54M, low $473.54M), average net income is $237.53M (high $237.53M, low $237.53M), average SG&A $726.36M (high $726.36M, low $726.36M), and average EPS is $4.37 (high $4.37, low $4.37). MASI's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $2.37B (high $2.37B, low $2.37B), average EBITDA is $502.72M (high $502.72M, low $502.72M), average net income is $272.32M (high $272.32M, low $272.32M), average SG&A $771.12M (high $771.12M, low $771.12M), and average EPS is $5.02 (high $5.02, low $5.02).
Did the MASI's actual financial results beat the analysts' financial forecasts?
Based on Masimo's last annual report (Dec 2023), the company's revenue was $2.05B, which missed the average analysts forecast of $2.08B by -1.33%. Apple's EBITDA was $262.6M, missing the average prediction of $391.49M by -32.92%. The company's net income was $81.5M, missing the average estimation of $164.4M by -50.43%. Apple's SG&A was $664M, beating the average forecast of $604.63M by 9.82%. Lastly, the company's EPS was $1.51, missing the average prediction of $2.98 by -49.39%. In terms of the last quarterly report (Dec 2023), Masimo's revenue was $548.9M, beating the average analysts' forecast of $545.69M by 0.59%. The company's EBITDA was $87.4M, missing the average prediction of $115.57M by -24.38%. Masimo's net income was $34M, missing the average estimation of $49.01M by -30.62%. The company's SG&A was $159.8M, missing the average forecast of $177.28M by -9.86%. Lastly, the company's EPS was $0.63, missing the average prediction of $0.902 by -30.19%